| PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors MA Curran, W Montalvo, H Yagita, JP Allison Proceedings of the National Academy of Sciences 107 (9), 4275-4280, 2010 | 2097 | 2010 |
| PD-L1 expression in triple-negative breast cancer EA Mittendorf, AV Philips, F Meric-Bernstam, N Qiao, Y Wu, S Harrington, ... Cancer immunology research 2 (4), 361-370, 2014 | 1330 | 2014 |
| CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells SA Quezada, KS Peggs, MA Curran, JP Allison The Journal of clinical investigation 116 (7), 1935-1945, 2006 | 797 | 2006 |
| Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype K Gabrusiewicz, B Rodriguez, J Wei, Y Hashimoto, LM Healy, SN Maiti, ... JCI insight 1 (2), 2016 | 432 | 2016 |
| Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16–related cancer: a phase 2 clinical trial E Massarelli, W William, F Johnson, M Kies, R Ferrarotto, M Guo, L Feng, ... JAMA oncology 5 (1), 67-73, 2019 | 425 | 2019 |
| Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer S Chouaib, MZ Noman, K Kosmatopoulos, MA Curran Oncogene 36 (4), 439-445, 2017 | 335 | 2017 |
| Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy P Jayaprakash, M Ai, A Liu, P Budhani, T Bartkowiak, J Sheng, C Ager, ... The Journal of clinical investigation 128 (11), 5137-5149, 2018 | 317 | 2018 |
| Ipilimumab with stereotactic ablative radiation therapy: phase I results and immunologic correlates from peripheral T cells C Tang, JW Welsh, P De Groot, E Massarelli, JY Chang, KR Hess, S Basu, ... Clinical Cancer Research 23 (6), 1388-1396, 2017 | 303 | 2017 |
| 4-1BB agonists: multi-potent potentiators of tumor immunity T Bartkowiak, MA Curran Frontiers in oncology 5, 117, 2015 | 291 | 2015 |
| Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression Q Hu, Y Ye, LC Chan, Y Li, K Liang, A Lin, SD Egranov, Y Zhang, W Xia, ... Nature immunology 20 (7), 835-851, 2019 | 283 | 2019 |
| Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production MA Curran, M Kim, W Montalvo, A Al-Shamkhani, JP Allison PloS one 6 (4), e19499, 2011 | 275 | 2011 |
| PD-L1 expression in triple-negative breast cancer. Cancer Immunol. Res. 2014; 2: 361–370. doi: 10.1158/2326-6066 EA Mittendorf, AV Philips, F Meric-Bernstam, N Qiao, Y Wu, S Harrington, ... CIR-13-0127.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 241 | |
| Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin MA Curran, TL Geiger, W Montalvo, M Kim, SL Reiner, A Al-Shamkhani, ... Journal of Experimental Medicine 210 (4), 743-755, 2013 | 205 | 2013 |
| STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial MJ Reilley, P McCoon, C Cook, P Lyne, R Kurzrock, Y Kim, R Woessner, ... Journal for immunotherapy of cancer 6, 1-10, 2018 | 198 | 2018 |
| Development of immunotherapy combination strategies in cancer TA Yap, EE Parkes, W Peng, JT Moyers, MA Curran, HA Tawbi Cancer discovery 11 (6), 1368-1397, 2021 | 175 | 2021 |
| Intratumoral STING activation with T-cell checkpoint modulation generates systemic antitumor immunity CR Ager, MJ Reilley, C Nicholas, T Bartkowiak, AR Jaiswal, MA Curran Cancer immunology research 5 (8), 676-684, 2017 | 162 | 2017 |
| Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors MA Curran, SM Kaiser, PL Achacoso, GP Nolan Molecular Therapy 1 (1), 31-38, 2000 | 159 | 2000 |
| Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors MA Curran, JP Allison Cancer research 69 (19), 7747-7755, 2009 | 158 | 2009 |
| Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications J Wei, P Chen, P Gupta, M Ott, D Zamler, C Kassab, KP Bhat, MA Curran, ... Neuro-oncology 22 (2), 180-194, 2020 | 151 | 2020 |
| PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity SL Buchan, M Fallatah, SM Thirdborough, VY Taraban, A Rogel, ... Clinical cancer research 24 (10), 2383-2394, 2018 | 105 | 2018 |
